Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/MAT.0000000000001177 http://scihub22266oqcxt.onion/10.1097/MAT.0000000000001177 32304395!7217124!32304395     free     free     free Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 225.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32304395.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       ASAIO+J 2020 ; 66 (6): 603-606 Nephropedia Template TP {{tp|p=32304395|t=2020. COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support |pdf=|usr=}}{{32304395}} gab.com Text COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support JO: ASAIO J http://www.kidney.de/pget.php?&tw=1&pmid=32304395 #FOAvip The outbreak of novel coronavirus (SARS-CoV-2) that causes the respiratory illness COVID-19 has led to unprecedented efforts at containment due to its rapid community spread, associated mortality, and lack of immunization and treatment. We herein detail a case of a young patient who suffered life-threatening disease and multiorgan failure. His clinical course involved rapid and profound respiratory decompensation such that he required support with venovenous extracorporeal membrane oxygenation (VV-ECMO). He also demonstrated hyperinflammation (C-reactive protein peak 444.6 mg/L) with severe cytokine elevation (Interleukin-6 peak > 3000 pg/ml). Through treatment targeting hyperinflammation, he recovered from critical COVID-19 respiratory failure and required only 160 hours of VV-ECMO support. He was extubated 4 days after decannulation, had progressive renal recovery, and was discharged to home on hospital day 24. Of note, repeat SARS-CoV-2 test was negative 21 days after his first positive test. We present one of the first successful cases of VV-ECMO support to recovery of COVID-19 respiratory failure in North America. Twit Text FOAVip COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support ????ASAIO J http://www.kidney.de/pget.php?&tw=1&pmid=32304395 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32304395 #FOAvip English Wikipedia <ref>{{Cite pmid|32304395}}</ref> COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Support #MMPMID32304395 Hartman ME; Hernandez RA; Patel K; Wagner TE; Trinh T; Lipke AB; Yim ET; Pulido JN; Pagel JM; Youssef SJ; Mignone JL ASAIO J 2020[Jun]; 66 (6): 603-606 PMID32304395show ga The outbreak of novel coronavirus (SARS-CoV-2) that causes the respiratory illness COVID-19 has led to unprecedented efforts at containment due to its rapid community spread, associated mortality, and lack of immunization and treatment. We herein detail a case of a young patient who suffered life-threatening disease and multiorgan failure. His clinical course involved rapid and profound respiratory decompensation such that he required support with venovenous extracorporeal membrane oxygenation (VV-ECMO). He also demonstrated hyperinflammation (C-reactive protein peak 444.6 mg/L) with severe cytokine elevation (Interleukin-6 peak > 3000 pg/ml). Through treatment targeting hyperinflammation, he recovered from critical COVID-19 respiratory failure and required only 160 hours of VV-ECMO support. He was extubated 4 days after decannulation, had progressive renal recovery, and was discharged to home on hospital day 24. Of note, repeat SARS-CoV-2 test was negative 21 days after his first positive test. We present one of the first successful cases of VV-ECMO support to recovery of COVID-19 respiratory failure in North America. |*Betacoronavirus[MESH] |*Extracorporeal Membrane Oxygenation[MESH] |Adult[MESH] |COVID-19[MESH] |Coronavirus Infections/*complications[MESH] |Cytokines/immunology[MESH] |Humans[MESH] |Inflammation/immunology[MESH] |Male[MESH] |Pandemics[MESH] |Patient Discharge[MESH] |Pneumonia, Viral/*complications[MESH] |Respiratory Insufficiency/etiology/*therapy[MESH]COVID-19 Respiratory Failure: Targeting Inflammation on VV-ECMO Suppor(epmc).pdf DeepDyve Pubget Overpricing